GENE

Genetic Technologies Ltd

1.77 USD
+0.02 (+1.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Genetic Technologies Ltd stock is down -22.37% since 30 days ago. The next earnings date is Jul 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 10.53% of the previous 18 June’s closed higher than May.

About Genetic Technologies Ltd

Genetic Technologies Limited provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. Its lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. The company also develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma.